Lannett Co Inc (LCI) : During the past 4 weeks, traders have been relatively bearish on Lannett Co Inc (LCI), hence the stock is down -15.97% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -11.31% relative to the S&P 500. The 4-week change in the price of the stock is -16.42% and the stock has fallen -11.17% in the past 1 week.
The stock has recorded a 20-day Moving Average of 14% and the 50-Day Moving Average is 15.76%.The 200 Day SMA reached 1.65%
Lannett Co Inc (NYSE:LCI): The stock opened in the green at $26.79 on Friday, but the bulls found it difficult to push the prices higher. The stock reached a high of $27.35 and a low of $26.34 for the day. The stock did not find buyers even at the lows and closed at $26.57 recording a loss of -0.82%. 945,375 shares exchanged hands during the trading day. The stock had closed at $26.57 in the previous days trading.
Lannett Co Inc (LCI) : Currently there are 4 street experts covering Lannett Co Inc (LCI) stock. The most bullish and bearish price target for the stock is $49 and $32 respectively for the short term. The average price target of all the analysts comes to $41. The estimated standard deviation from the target is $7.07.
Lannett Company, Inc. develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. The Companys products include Levothyroxine Sodium tablets, Digoxin tablets, Butalbital products, Ursodiol capsules and pain management products. Levothyroxine Sodium tablets are produced and marketed with around 12 varying potencies. Digoxin tablets are produced and marketed with approximately two different potencies. It distributes around three products containing Butalbital. Ursodiol capsules are produced and marketed in 300 milligram capsules. The Company offers a range of pain management products, such as Cocaine Topical Solution (C-Topical), Morphine Sulfate Oral Solution, Hydromorphone hydrochloric acid (HCl) tablets and Codeine Sulfate tablets.